Cancer and mTOR inhibitors in kidney transplantation recipients

BACKGROUND: Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. METHODS: In the current study, patients were registered in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PeerJ
Autori principali: Kao, Chih-Chin, Liu, Jia-Sin, Chang, Yu-Kang, Lin, Ming-Huang, Lin, Yen-Chung, Chen, Hsi-Hsien, Chang, Wei-Chiao, Hsu, Chih-Cheng, Wu, Mai-Szu
Natura: Artigo
Lingua:Inglês
Pubblicazione: PeerJ Inc. 2018
Soggetti:
Internal Medicine
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237112/
https://ncbi.nlm.nih.gov/pubmed/30473931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.5864
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi